Clinical trial · Interventional
Hemopatch Implication After Axillary Dissection for Breast Cancer
Hemopatch Implication After Axillary Dissection for Breast Cancer: a Randomized Clinical Study
NCT06744998CI-TRIAL-00083993BreastPatchnot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Aim of this randomized study is to assess the value of a different haemostatic sealant, the Hemopatch®, in axillary lymph node dissection (ALND) to reduce the incidence of seroma and seroma-related complications.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hemopatch® (Baxter) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Hemopatch® group
- description
- Hemopatch® application after axillary dissection
- interventionNames
- Device: Hemopatch® (Baxter)
- type
- NO_INTERVENTION
- label
- No Hemopatch® group
- description
- No Hemopatch® application after axillary dissection
Primary outcomes (1)
- measure
- Axillary seroma evaluation
- timeFrame
- 1 week
- description
- Measure of drain output (in cc) in one week
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with primary breast cancer * Mastectomy or breast conserving surgery * Patients eligible for axillary dissection * Male or female * Any age * Previous (or not) neoadjuvant treatments * Any breast histotypes Exclusion Criteria: * Previous axillary surgery
References
Publications (0)
Data not yet available
No reference posted for this study.